There are 15,358 results relating to "Medicin Viagra-m"
Order by
|
Questions and Answers
Date answered:
1 December 2025
S6W-41915
There is no requirement to hold a WDA where medicinal products are being transferred between different locations within the same legal entity, for example from a Health Board managed pharmacy department to a Health Board managed vaccination clinic.The Medicines and Healthcare products Regulatory Agency (MHRA) is resp...
Questions and Answers
Date answered:
18 September 2025
S6W-40173
The cost of the medicine is not a decision-making criterion.
Questions and Answers
Date answered:
11 December 2023
S6W-23411
To ask the Scottish Government what assessment it has made of making medicinal cannabis more widely available on the NHS for adults with epilepsy.
Questions and Answers
Date answered:
8 November 2021
S6W-03701
In September 2020, the Scottish Medicines Consortium (SMC) accepted siponimod (Mayzent®) for routine use in NHS Scotland.
Questions and Answers
Date answered:
8 November 2021
S6W-03513
The Scottish Genomics Leadership Group, jointly chaired by Professor David Crossman, Chief Scientist for Health for the Scottish Government, and Susan Buchanan, Director for NHS National Services Division, are our expert group in genomic medicine and are providing advice to the Scottish Government to plan our long-term agenda for genomic medicine in Scotland.
Last updated:
9 March 2026
202602_ConvToMinister_PE2099
The British Association of Perinatal Medicine set out that the survival of babies born Contact: Citizen Participation and Public Petitions Committee, The Scottish Parliament, Edinburgh, EH99 1SP.
Last updated:
10 May 2023
Patient Safety Commissioner for Scotland Stage 1 report response
Gathering and use of information Requiring information from private companies I agree in principle with the Committee’s view that the powers to compel organisations to provide information under section 12 of the Bill should encompass private companies that provide medicines and medical devices. The Medicines and Healthcare products Regulatory Agency (MHRA) has responsibility for the regulation of manufacturers and sellers of medicines and medical devices across the whole of the UK.
Last updated:
6 December 2021
Minutes of the CPG on Lung Health meeting of 27 September 2021
. • Maureen Ward spoke on behalf of Action for Pulmonary Fibrosis to request that the CPG endorse calls from APF for the Scottish Medicine Consortium to lift restrictions for anti- fibrotic medicines for patients with IPF.
Official Report
Meeting date:
5 November 2020
Culture, Tourism, Europe and External Affairs Committee 05 November 2020
That is the case for only a small number of medicines, but those medicines are of a very critical nature.
Questions and Answers
Date answered:
28 March 2025
S6W-35676
During my time in office I have had the honour to meet with children, young people, families and workforce across the country to see and hear of the impact of the projects and initiatives that are underway.This includes work supported by our multi-year commitment to funding Children’s Services Planning Partnerships to transform family support in their local areas which was recently raised from £32 m...
